Since their discovery in the first half of the 20th century, antimicrobial drugs have saved countless lives and transformed human and animal health. As we’ve discussed in previous Executive Insights, antimicrobial resistance (AMR) is a growing threat to public health across the globe, creating huge implications for human and animal health. The mounting pressure by regulators in Europe and the U.S. to combat this has started with limiting the use of antimicrobials in animal health, thereby putting at risk a foundational segment of today’s animal health market.
Although the extent and causes of AMR are increasingly understood, the solutions required to stem the tide of AMR are complex. In this Executive Insights, we explore the evolving industry dynamics and implications for the animal health industry and lay out opportunities for the industry to turn this trend from a threat to a driver for growth.